Find Alzheimer’s Disease and Related Clinical Trials
Featured Alzheimer's Disease Clinical Trials
Purpose: To determine the relationships among clinical, cognitive, imaging, genetic, and biomarker characteristics of the entire spectrum of Alzheimer's disease.
Purpose: To test whether an anti-amyloid investigational drug, solanezumab, can slow memory and cognitive decline in older individuals who do not yet show symptoms of Alzheimer's disease cognitive impairment or dementia.
Purpose: To evaluate the effects of physical exercise on cognition, functional status, brain atrophy, blood flow, and cerebrospinal fluid biomarkers of Alzheimer's disease in adults with a mild memory impairment.
Purpose: To improve the cognitive and mental health of Alzheimer's disease caregivers by testing a mobile app that provides support and assistance.
Can't find a trial that fits you?
Get More Information
Contact NIA's Alzheimer's Disease Education and Referral Center. We’re here to help!
1-800-438-4380 (toll-free; English & Spanish)
Mon-Fri, 8:30 am-5:00 pm Eastern Time
or send an email to: email@example.com